14 unknown, 2 not yet recruiting, 1 active not recruiting, 1 completed. 18 Phase 2, 7 Phase 1, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 18 | Unknown 14, Not yet recruiting 2, Active not recruiting 1, Completed 1 |
| Phase 1 | 7 | Unknown 4, Active not recruiting 1, Completed 1, Not yet recruiting 1 |
| Phase 3 | 3 | Unknown 3 |
Follow MSCs: new trials by email Literature Review of MSCs trials Research Report on MSCs
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Autologous Stem Cell Therapy in Patients With Multiple System Atrophy MSCs, Placebo - MSA - Multiple System Atrophy, MSA | Phase 2 | Not yet recruiting | Biocells Medical | 50 | 2026-09-01 | 2026-03-11 |
| Mesenchymal Stem Cells for Chronic Kidney Diseases 0.9% sodium chloride, MSCs - Kidney Disease, Chronic, Diabetic Kidney Disease (DKD) | Phase 1 / Phase 2 | Not yet recruiting | The First Affiliated Hospital of Air Force Medicial University | 32 | 2026-01-01 | 2025-12-24 |
| Effectiveness and Safety of Mesenchymal Stem Cell Therapy in Long COVID Patients umbilical cord mesenchymal stem cell - Long COVID, Post-Acute COVID-19 Syndrome | Phase 1 / Phase 2 | Unknown | Changhai Hospital | 76 | 2023-09-01 | 2024-07-09 |
| Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis MSCs, Saline - Multiple Sclerosis, Progressive Multiple Sclerosis | Phase 1 / Phase 2 | Active not recruiting | Haukeland University Hospital | 18 | 2021-08-09 | 2026-03-12 |
| Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease) Mesenchymal Stromal Cells, Supportive Care - Sars-CoV2, Acute Respiratory Distress Syndrome | Phase 1 / Phase 2 | Completed | Baylor College of Medicine | 28 | 2021-02-12 | 2026-10-21 |
| Mesenchymal Stem Cell Infusion for COVID-19 Infection Mesenchymal stem cells, Placebo - COVID-19 | Phase 2 | Unknown | Dr. Zaineb Akram | 20 | 2020-05-01 | 2020-06-30 |
| MSC for Severe aGVHD MSCs - Steroid-resistant Severe aGVHD | Phase 2 / Phase 3 | Unknown | Fujian Medical University | 50 | 2017-12-01 | 2018-08-15 |
| Mesenchymal Stromal Cell Derivatives in the Treatment of Chronic Diabetic Foot Ulcers Type 1 and 2 dac-MSCs, MSCs, Fitostimoline - Foot Ulcer, Diabetic | Phase 1 / Phase 2 | Unknown | Universidad Autónoma de Bucaramanga | 51 | 2017-01-01 | 2016-10-24 |
| Rituximab Combined With MSCs in the Treatment of PNS (3-4 Stage of CKD) Rituximab, conventional therapy, Mesenchymal stem cells - Renal Insufficiency, Chronic, Nephrotic Syndrome | Phase 2 | Unknown | Zhujiang Hospital | 116 | 2016-08-01 | 2016-11-22 |
| MSC for Treatment of Interstitial Lung Disease After Allo-HSCT MSCs, AZM, Glucocorticoid - Lung Diseases, Interstitial, Hematopoietic Stem Cell Transplantation | Phase 1 / Phase 2 | Unknown | Nanfang Hospital, Southern Medical University | 60 | 2014-09-01 | 2017-05-10 |
| MSCs With or Without Peripheral Blood Stem Cell for Treatment of Poor Graft Function and Delayed Platelet Engraftment PBSC, MSCs - Stem Cell Transplantation, Hematopoietic, Poor Graft Function | Phase 2 / Phase 3 | Unknown | Nanfang Hospital, Southern Medical University | 120 | 2014-09-01 | 2014-09-16 |
| MSCs Combined With CD25 Monoclonal Antibody and Calcineurin Inhibitors for Treatment of Steroid-resistant aGVHD CD25 monoclonal antibody, calcineurin inhibitors, MSCs - Acute Graft-versus-host Disease | Phase 2 / Phase 3 | Unknown | Nanfang Hospital, Southern Medical University | 200 | 2014-09-01 | 2014-09-16 |
| MSC for Treatment of CMV Infection MSCs - Stem Cell Transplantation, Hematopoietic, CMV Infection | Phase 2 | Unknown | Nanfang Hospital, Southern Medical University | 120 | 2014-01-01 | 2015-01-07 |
| Testicular Injection of Autologous Stem Cells for Treatment of Patients With Azoospermia Stem Cells - Azoospermia | Phase 1 / Phase 2 | Unknown | Hesham Saeed Elshaer | 60 | 2014-01-01 | 2014-01-22 |
| Peripheral Blood Stem Cell Combined With Mesenchymal Stem Cells for Treatment of Poor Graft Function PBSC, MSCs - Stem Cell Transplantation, Hematopoietic, Poor Graft Function | Phase 2 | Unknown | Nanfang Hospital, Southern Medical University | 120 | 2014-01-01 | 2014-03-11 |
| Mesenchymal Stem Cells for Treatment of Refractory Acute Graft-versus-host Disease Mesenchymal stem cells, Non-mesenchymal stem cells - Acute Graft-versus-host Disease | Phase 2 | Unknown | Nanfang Hospital, Southern Medical University | 40 | 2013-01-01 | 2013-01-10 |
| Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-versus-host Disease Mesenchymal stem cells, Non-mesenchymal stem cells - Chronic Graft-versus-host Disease | Phase 2 | Unknown | Nanfang Hospital, Southern Medical University | 60 | 2013-01-01 | 2013-01-10 |
| MSC Administration for the Management of Type 1 Diabetic Patients MSCs - Type 1 Diabetes Mellitus | Phase 2 | Unknown | Universidad del Desarrollo | 10 | 2012-03-01 | 2016-09-08 |
Hematologic Diseases (3) · COVID-19 (2) · Renal Insufficiency, Chronic (2) · Azoospermia (1) · Bronchiolitis Obliterans (1) · Bronchiolitis Obliterans Syndrome (1) · Coronavirus Infections (1) · Cytomegalovirus Infections (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 1 (1) · Diabetic Foot (1) · Diabetic Nephropathies (1) · Disease Progression (1) · Hypertensive Nephropathy (1) · Insulin Resistance (1)
Nanfang Hospital, Southern Medical University (7) · Baylor College of Medicine (1) · Biocells Medical (1) · Changhai Hospital (1) · Dr. Zaineb Akram (1) · Fujian Medical University (1) · Haukeland University Hospital (1) · Hesham Saeed Elshaer (1) · The First Affiliated Hospital of Air Force Medicial University (1) · Universidad Autónoma de Bucaramanga (1) · Universidad del Desarrollo (1) · Zhujiang Hospital (1)
China (10) · Chile (1) · Egypt (1) · Norway (1) · Pakistan (1) · Poland (1) · United States (1)
Qifa Liu, MD (3) · Qifa Liu (2) · Qifa Liu, MD. (2) · Christopher Elnan Kvistad, PhD (1) · Claudia L Sossa-Melo, MD (1) · Claudio Mizon, MD (1) · Hala Gabr, MD (1) · Helen Heslop, MD (1) · LaQuisa Hill, MD (1) · Paulette Conget, PhD (1) · Sayed Bakry, PhD (1) · Taimour Khalifa, MD (1) · Tang Xun, doctor (1) · Wael Abu El Khier, MD (1)